Skip to main content
. Author manuscript; available in PMC: 2008 Sep 30.
Published in final edited form as: Methods Enzymol. 2005;399:585–609. doi: 10.1016/S0076-6879(05)99039-3

FIG. 3.

FIG. 3

The mechanism of proteasome inhibition by epoxomicin is proposed on the basis of the x-ray structure of yeast 20S proteasome–epoxomicin complex. It is postulated that the unique specificity of epoxomicin is due to the formation of an unusual six-membered morpholino ring between Thr-1 of the catalytic subunit of 20S proteasome and the α′,β′-epoxyketone pharmacophore of epoxomicin.